Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
PreveCeutical Medical Inc. (PRVCF) had Free Cash Flow per Share of $-0.00 for the most recently reported fiscal quarter, ending 2024-09-30.
| Income Statement Financials | |
-- |
|
$-0.25M |
|
-- |
|
-- |
|
$0.18M |
|
$-0.18M |
|
$-0.07M |
|
$-0.25M |
|
$-0.25M |
|
$-0.25M |
|
$-0.25M |
|
$-0.25M |
|
$-0.25M |
|
$-0.18M |
|
$-0.18M |
|
536.94M |
|
536.94M |
|
$-0.00 |
|
$-0.00 |
|
| Balance Sheet Financials | |
$0.25M |
|
$0.00M |
|
$0.08M |
|
$0.33M |
|
$4.89M |
|
$0.05M |
|
$0.05M |
|
$4.94M |
|
$-4.61M |
|
$-4.69M |
|
$-4.61M |
|
541.70M |
|
| Cash Flow Statement Financials | |
$-0.26M |
|
$-0.00M |
|
$0.27M |
|
$0.00M |
|
$0.00M |
|
$-0.00M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.05 |
|
-- |
|
-- |
|
-0.01 |
|
-0.68 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.27M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
5.34% |
|
5.25% |
|
-73.84% |
|
5.40% |
|
$-0.01 |
|
|
Free Cash Flow per Share |
$-0.00 |
$-0.00 |
|